Navigation Links
Complete Genomics and Illumina Settle Patent Litigation
Date:7/18/2013

MOUNTAIN VIEW, Calif., July 18, 2013 /PRNewswire/ -- Complete Genomics, Inc. (formerly NASDAQ: GNOM) ("Complete"), a wholly-owned subsidiary of BGI-Shenzhen ("BGI"), a leading international genomics organization based in Shenzhen, China, today announced that it has entered into a settlement agreement with Illumina, Inc. under which Illumina will dismiss with prejudice both lawsuits it had brought against Complete:  Illumina, Inc. and Solexa, Inc. v. Complete Genomics, Inc., Case No. 10-cv-05542 EDL (N.D. Cal.); and Illumina, Inc. and Illumina Cambridge Ltd. v. Complete Genomics, Inc., Case No. 12-cv-01465 BEN BGS (S.D. Cal).  Complete will dismiss with prejudice all counterclaims.  The parties have entered into mutual releases, and each party will bear its own litigation costs.  No payment is being made by either party to the other, and no licenses are being granted by either party to the other.

"We are pleased to have reached a settlement with Illumina regarding this matter.  This resolution allows Complete to focus on its vision of revolutionizing medicine through the use of whole genome sequencing," Dr. Clifford Reid, CEO of Complete, said.

About Complete

Complete Genomics provides the most accurate whole human genome sequencing available today. The company's proprietary sequencing technology and advanced informatics and analysis software provide researchers and clinicians worldwide with the genomic information needed to better understand the prevention, diagnosis, and treatment of diseases. Additional information can be found at http://www.completegenomics.com.


'/>"/>
SOURCE Complete Genomics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Complete Titrator Systems from Cole-Parmer Offer Easy-To-Use Apps-Based Interface
2. Replicel and Shiseido Complete Collaboration and Technology Transfer Agreement on Technology for Treating Pattern Baldness
3. Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab
4. Oligomerix, Inc. Completes Series B Financing
5. Leviticus Cardio Ltd. Completes a Successful Animal Trial for its Wireless Energy System for VADs
6. St. Mary Completes Phase 2 of Its Emergency Department and Trauma Center Expansion
7. Centene Corporation Completes Acquisition Of Specialty Pharmacy Leader AcariaHealth
8. bioRASI Completes Acquisition of Ukrainian CRO
9. Novira Therapeutics Completes $25 Million Series A Financing
10. SoundMindz TM Releases ‘Anti-Anxiety TM’ Mobile App - A Complete Stress Therapy Program
11. BGI-Shenzhen Completes Acquisition of Complete Genomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):